Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.

Abstract

Sulfasalazine was effective in PsA, with efficacy observed as early as the 4th week of treatment. Longterm studies are needed to determine whether such therapy can modify disease outcome.